Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-01-11
2011-01-11
Andres, Janet L. (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07868188
ABSTRACT:
The invention provides thiazole derivatives of formula (I), or pharmaceutically acceptable salts thereof in which Ring A, R1, R2and R3are as defined in the specification; a processes for their preparation; pharmaceutical compositions containing them; and their use in therapy, for example in the treatment of disease mediated by a PI3K enzyme and/or a mTOR kinase.
REFERENCES:
patent: 4649146 (1987-03-01), Takaya et al.
patent: 4735957 (1988-04-01), Takaya et al.
patent: 0 117 082 (1984-08-01), None
patent: WO 0049015 (2000-08-01), None
patent: WO 03/072557 (2003-09-01), None
patent: WO 2004/078754 (2004-09-01), None
patent: WO 2004/096797 (2004-11-01), None
Arnould Jean-Claude
Bailey John Peter
Bengtsson Malena
Bird Thomas Geoffrey Colerick
Griffen Edward Jolyon
Andres Janet L.
Astrazeneca AB
Covington Raymond
LandOfFree
5-heteroaryl thiazoles and their use as PI3K inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-heteroaryl thiazoles and their use as PI3K inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-heteroaryl thiazoles and their use as PI3K inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2653474